-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Progyny, Lowers Price Target to $23

Benzinga·03/20/2026 13:28:16
Listen to the news
Barclays analyst Glen Santangelo maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $29 to $23.